Susan Dexter - Net Worth and Insider Trading
Susan Dexter Net Worth
The estimated net worth of Susan Dexter is at least $55,551 dollars as of 2024-05-27. Susan Dexter is the Chief Technical Officer of Sonnet BioTherapeutics Holdings Inc and owns about 33,667 shares of Sonnet BioTherapeutics Holdings Inc (SONN) stock worth over $55,551. Details can be seen in Susan Dexter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Susan Dexter has not made any transactions after 2023-06-14 and currently still holds the listed stock(s).
Transaction Summary of Susan Dexter
Susan Dexter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan Dexter owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .
Click here to see the complete history of Susan Dexter’s form 4 insider trades.
Insider Ownership Summary of Susan Dexter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-06-14 | Chief Technical Officer |
Susan Dexter Latest Holdings Summary
Susan Dexter currently owns a total of 1 stock. Susan Dexter owns 33,667 shares of Sonnet BioTherapeutics Holdings Inc (SONN) as of June 14, 2023, with a value of $55,551.
Latest Holdings of Susan Dexter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2023-06-14 | 33,667 | 1.65 | 55,551 |
Holding Weightings of Susan Dexter
Susan Dexter Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan Dexter has made a total of 1 transactions in Sonnet BioTherapeutics Holdings Inc (SONN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sonnet BioTherapeutics Holdings Inc is the acquisition of 10,000 shares on June 14, 2023, which cost Susan Dexter around $7,000.
Insider Trading History of Susan Dexter
- 1
Susan Dexter Trading Performance
GuruFocus tracks the stock performance after each of Susan Dexter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan Dexter is -77.31%. GuruFocus also compares Susan Dexter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan Dexter within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Susan Dexter's insider trading performs compared to the benchmark.
Performance of Susan Dexter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -40.5 |  | | | | |
| Relative Return to S&P 500(%) | -43.54 | | | | | |
Susan Dexter Ownership Network
Susan Dexter Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Susan Dexter is the Chief Technical Officer of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , director & Chairman & President and CEO Pankaj Mohan , and Chief Medical Officer Richard T Kenney .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, Susan Dexter made 1 insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN) with a net purchase of 10,000. Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 431,600 shares made by Pankaj Mohan , a net purchase of 25,000 shares made by Nailesh Bhatt , and a net purchase of 23,255 shares made by Albert D. Dyrness .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 489,855 shares were bought by its insiders, resulting in a net purchase of 489,855 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Susan Dexter Mailing Address
Above is the net worth, insider trading, and ownership report for Susan Dexter. You might contact Susan Dexter via mailing address: C/o Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton Nj 08540.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
